Standard Operating Procedure (SOP): Clinical Management and Control of Malaria

This Standard Operating Procedure (SOP) outlines the clinical protocol for the identification, diagnosis, treatment, and containment of malaria cases within a healthcare facility. The objective is to ensure standardized patient care, minimize diagnostic delays, and reduce morbidity and mortality through evidence-based practices aligned with World Health Organization (WHO) guidelines. All clinical staff, including triage officers, laboratory technicians, and prescribing physicians, must adhere strictly to these protocols to maintain patient safety and epidemiological integrity.

Phase 1: Patient Triage and Clinical Assessment

• Initial Triage: Screen all patients presenting with febrile illness using the "Malaria Fever Questionnaire" (recent travel to endemic areas, history of fever/chills).
• Vitals Monitoring: Record temperature, pulse, blood pressure, and respiratory rate immediately.
• Red Flag Identification: Assess for signs of severe malaria: altered mental status, seizures, severe vomiting, hemoglobinuria (dark urine), jaundice, or signs of acute respiratory distress.
• Immediate Isolation/Stabilization: If a patient is unstable, move to the Emergency/Resuscitation area for immediate stabilization before formal diagnostic testing.

Phase 2: Diagnostic Verification

• Sample Collection: Collect capillary blood via finger prick (or venous blood, if required) using aseptic techniques.
• Rapid Diagnostic Test (RDT): Perform an RDT for P. falciparum and P. vivax immediately. Results should be recorded within 20 minutes.
• Microscopy: If RDT is negative but clinical suspicion remains high, prepare thick and thin blood smears for Giemsa staining and manual microscopic examination.
• Documentation: Record all results (positive/negative/parasite density) in the Patient Electronic Health Record (EHR).

Phase 3: Treatment Administration

• Uncomplicated Malaria: Administer Artemisinin-based Combination Therapy (ACT) as per national guidelines. Verify the patient’s weight for accurate dosing.
• Severe Malaria: Administer intravenous Artesunate as the first-line treatment for adults and children, followed by a full course of ACT once the patient can tolerate oral medication.
• Supportive Care: Manage pyrexia with antipyretics (Paracetamol) and hydration status with IV fluids (balanced against the risk of pulmonary edema).
• Direct Observation: Ensure the patient consumes the first dose of medication under direct clinical supervision to verify tolerance and prevent vomiting.

Phase 4: Follow-up and Case Reporting

• Monitoring: Conduct daily clinical rounds to assess for signs of clinical failure (persistent fever after 48 hours) or complications.
• Data Reporting: Submit all confirmed positive cases to the local health authority’s infectious disease database within 24 hours for surveillance purposes.
• Discharge Education: Provide patient counseling on medication adherence, the importance of bed net usage, and clear instructions on return symptoms that require immediate emergency care.

Pro Tips & Pitfalls

• Pro Tip: Always weigh the patient; dosing based on "visual estimation" of age frequently leads to sub-therapeutic dosing in children, contributing to drug resistance.
• Pitfall - The "Negative" Trap: Do not automatically rule out malaria if a patient has been on recent antibiotics or antimalarials, as these can suppress parasitemia below detectable levels.
• Pro Tip: In patients with severe malaria, monitor blood glucose levels closely; hypoglycemia is a frequent, life-threatening complication of quinine or artesunate therapy.
• Pitfall: Over-reliance on RDTs in high-transmission areas can lead to missing mixed-infection cases; maintain high clinical suspicion if the patient remains febrile.

Frequently Asked Questions (FAQ)

1. What should I do if the RDT is negative but the patient is clearly ill? If clinical suspicion remains high, repeat the test using high-quality microscopy (thick/thin smears) and investigate for alternative causes of fever such as Dengue, Typhoid, or bacterial sepsis.

2. Is it safe to treat pregnant women for malaria? Yes. Malaria in pregnancy is a medical emergency. Treatment must follow the specific national guidelines for trimester-appropriate antimalarials to prevent severe maternal and fetal complications.

3. When should a patient be transitioned from IV Artesunate to oral therapy? Transition should occur as soon as the patient can swallow oral medication and demonstrates clinical improvement, usually within 24–48 hours, ensuring a full course of the prescribed ACT is completed.